Company intelligence / Profile preview

VivaChek Biotech

Hangzhou, Zhejiang, Chinavivachek.com ↗

Ownership: Private
Development stage: Commercial

Overview

VivaChek Biotech develops and manufactures point-of-care diagnostic devices with a global presence. Its core products—blood glucose monitoring systems—have received multiple FDA clearances. The company also offers multi-analyte meters for glucose and ketones, urine analyzers, cholesterol/coagulation/hemoglobin handhelds, drugs of abuse tests including the first FDA-cleared OTC fentanyl test kit. Clinical studies have demonstrated usability by laypersons for their meters; non-clinical studies met acceptance criteria for accuracy.

Therapeutic areas: OtherPsychiatryEndocrinology
Modalities: DeviceDiagnostic test kitDigital health solution
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on VivaChek Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VivaChek Biotech.

Explore the full profile